FBRX - Forte Biosciences Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 2024-08-16    (Delayed quote data   2025-01-06)
Last
 22.60		 Change
 ⇓ -1.90   (-7.76%)		 Volume
  44,357
Open
 24.13		 High
 24.43		 Low
 22.40
8EMA (Daily)
 22.68		 40EMA (Daily)
 18.11		 50EMA (Daily)
 16.72		 STO (Daily)
 69.886		 MACD Hist (Daily)
 -0.141
8EMA (Weekly)
 20.358		 40EMA (Weekly)
 9.32		 50EMA (Weekly)
 8.01		 STO (Weekly)
 74.856		 MACD Hist (Weekly)
 2.446
Company Profile
Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com